Articles, Alerts & Updates
Regular Content
New to RXI?
Take a minute to review this brief outline.
J. Hall's Call on Innophos, Updated (PDF)
September 4, 2010 2:20 AM ET
Justin M. Hall's Call on KMG Chemicals, +7.5% in 3 Days
September 3, 2010 11:45 AM ET
September 3, 2010 9:30 AM ET
Sell BioScrip at $5
August 31, 2010 1:20 AM ET
Justin M. Hall's Call on Response Genetics
August 28, 2010 7:20 AM ET
Justin M. Hall's Call on Gold
August 28, 2010 3:00 AM ET
Immunogen Just Got Served by FDA
August 27, 2010 8:15 AM ET
Justin M. Hall's Call on Cereplast
August 26, 2010 9:30 PM ET
Epicept Likely to Succeed with Regulatory Challenge
August 24, 2010 5:25 AM ET
BioScrip Continues to Advance
August 23, 2010 2:45 PM ET
US Regulators Crush Epicept
August 23, 2010 9:15 AM ET
Epicept Advancing in Front of Priority Review
August 19, 2010 12:00 PM ET
Justin M. Hall's Call on Jazz Pharma (PDF)
August 19, 2010 9:00 AM ET
Ground Zero Mosque
August 19, 2010 at 1:00 AM ET
Would You Buy GM's IPO
August 9, 2010 2:35 PM ET
And 30 Days Later OXGN +30%, Remains a Buy
Augtust 9, 2010 10:36 AM ET
RXI Member Takes 200% Gain on Cypress Biosciences
Options Recommendation
August 3, 2010 5:00 AM ET
BioScrip Sell-Off Presents A Good Opportunity for Investors
July 31, 2010 6:00 AM ET
New Member Gets Results After 3 Weeks
June 14, 2010 4:45 AM ET
Are you looking forward to the 'change' coming to US healthcare?
July 26, 2010 5:20 AM ET
Justin M. Hall's Call on Cypress Biosciences (CYPB) (PDF)
July 22, 2010 6:20 AM ET
A Doc’s Take on Oxigene’s Ophthalmology Program
July 20, 2010 6:20 AM ET
Oxigene Dirt Cheap, Lots of Potential
July 15, 2010 3:00 PM ET
8 STRONG BUYS
Republished at Rx Investors on July 27, 2010 3:20 AM ET
Originally posted at Seeking Alpha on July 8, 2010 10:11 PM ET
Independence Day 2010
July 4, 2010
Persist Until You Succeed
June 25, 2010 3:07 AM ET
Spectrum Pharma: Looking Ahead at Continued Growth
Also published at Seeking Alpha on April 22, 2010
April 22, 2010
Anika: A Hidden Biotech Buy
A version of this article (PDF) was published at Seeking Alpha on April 23, 2010
April 20, 2010 10:31 PM ET
Infinity Pharma: Underappreciated Cancer Drug Maker
Published at Seeking Alpha on April 14, 2010
April 14, 2010
Justin M. Hall Featured in the
Orange County (California) Business Journal
March 22, 2010
Three Underappreciated Cancer Drug Makers
March 2, 2010
Spectrum Pharma: Additional Trial Not Required
January 27, 2010
December's Game Plan for Biotech
December 1, 2009
Spectrum Pharma: Zevalin Sales Ramp Up
November 22, 2009
Spectrum Pharma: CMS Rules in Favor of Zevalin
November 3, 2009
Spectrum Pharma: Zevalin Has Blockbuster Potential
October 25, 2009
On Small Cap Drug Makers and Volatility
October 18, 2009
Spectrum Pharma: Undervalued & Now Oversold
September 24, 2009
How Zevalin Is Helping Spectrum
Spectrum Pharma: Despite Share Offering,
Still Cheap vs. Other Cancer Drug Makers
September 20, 2009
Spectrum Pharma: Post-Zevalin Approval
Sales Should Ramp Up
September 11, 2009
Five Drug Makers with Pending Catalysts
September 1, 2009
SmartHeat: An Emerging Market Clean Energy Growth Play
August 27, 2009
Lucky 13 Portfolio: Fuel Systems & Three Cancer Drug Makers
August 25, 2009
Spectrum Pharma: The Labor Day Catalyst
August 20, 2009
Ariad Pharma: Significant Catalysts Approaching
August 14, 2009
Spectrum Pharma: Rumors of Buyout Talks Persist
August 10, 2009
These Small Cap Cancer Drug Makers Have Big Growth Potential
August 4, 2009
Spectrum Pharma: Potential Acquisition Target
August 2, 2009
Ariad Pharma: Advancing in Front of Interim Phase 3 Results
July 29, 2009
Spectrum Pharma: Outlook Looks Good
July 27, 2009
Spectrum Pharma: Importance of Zevalin Approval
July 19, 2009
Spectrum Pharma: Oversold and Undervalued
July 14, 2009
Spectrum Pharma: Temporary Setback
July 6, 2009
17 Reasons Why Spectrum May Eventually Be Acquired by Bayer, Alergan, or Teva Pharma
June 30, 2009
Spectrum Pharma: Optimistic About Zevalin's Prospects
June 28, 2009
Spectrum Pharma: Undervalued Growth Company
with Strong Late-Stage Pipeline
June 19, 2009
Two Possible Approvals for Spectrum Pharma
June 12, 2009